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Abstract
Aims/hypothesis—We conducted genome-wide association studies (GWASs) and expression
quantitative trait loci (eQTL) analyses to identify and characterise risk loci for type 2 diabetes in
Mexican-Americans from Starr County, TX, USA.
Method—Using 1.8 million directly interrogated and imputed genotypes in 837 unrelated type 2
diabetes cases and 436 normoglycaemic controls, we conducted Armitage trend tests. To improve
power in this population with high disease rates, we also performed ordinal regression including
an intermediate class with impaired fasting glucose and/or glucose tolerance. These analyses were
followed by meta-analysis with a study of 967 type 2 diabetes cases and 343 normoglycaemic
controls from Mexico City, Mexico.
Result—The top signals (unadjusted p value <1×10−5) included 49 single nucleotide
polymorphisms (SNPs) in eight gene regions (PER3, PARD3B, EPHA4, TOMM7, PTPRD, HNT
[also known as RREB1], LOC729993 and IL34) and six intergenic regions. Among these was a
missense polymorphism (rs10462020; Gly639Val) in the clock gene PER3, a system recently
implicated in diabetes. We also report a second signal (minimum p value 1.52× 10−6) within
PTPRD, independent of the previously implicated SNP, in a population of Han Chinese. Top
meta-analysis signals included known regions HNF1A and KCNQ1. Annotation of top association
signals in both studies revealed a marked excess of trans-acting eQTL in both adipose and muscle
tissues.
Conclusions/Interpretation—In the largest study of type 2 diabetes in Mexican populations to
date, we identified modest associations of novel and previously reported SNPs. In addition, in our
top signals we report significant excess of SNPs that predict transcript levels in muscle and
adipose tissues.
Keywords
Expression quantitative trait loci; Genome-wide association study; Meta-analysis; Mexican-
American; Type 2 diabetes
Introduction
Genome-wide association studies (GWASs) of type 2 diabetes in large samples of recent
European descent have identified a number of susceptibility loci; it is widely accepted that,
Below et al. Page 2
Diabetologia. Author manuscript; available in PMC 2013 September 04.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
to further understand the genetic aetiology of type 2 diabetes, it will be necessary to
replicate these findings and identify new loci using other populations. Mexican-Americans
have disproportionately high rates of type 2 diabetes. In order to identify genetic variants
contributing to type 2 diabetes susceptibility in Mexican-Americans we conducted both
binary trait and ordinal GWA on 1618 individuals from Starr County with diabetes (cases),
impaired glucose tolerance (IGT) or impaired fasting glucose (IFG), or normal fasting
glucose and glucose tolerance (controls), using nearly 2 million directly interrogated and
imputed markers. These analyses were combined in meta-analyses with the results from
GWASs of admixed Mexicans from Mexico City [1]. This sample is described in detail in
the companion paper. These cohorts comprise the largest type 2 diabetes analysis in
Mexican and Mexican-American samples to date. In addition, we followed our association
and meta-analyses by annotating SNPs with expression quantitative trait loci (eQTL)
information from lymphoblastoid cell lines (LCLs) as well as adipose and muscle tissues, to
characterise possible functional roles for SNPs associated with type 2 diabetes.
Methods
Study population and phenotype assessment
Using the 1979 National Diabetes Data Group criteria [2], cases (n=990) and controls
(n=990) were selected from genetic and epidemiological resources developed in the
Mexican-American population in Starr County, TX, USA (these also meet definitions set out
in the 1997 ADA criteria [3]). Of the 931 successfully genotyped case samples, we selected
837 unrelated individuals for our analyses.
A representative type 2 diabetes control sample was selected from a systematic survey of the
primary population centres of Starr County conducted from 2002 to 2006. Blocks were
randomly selected within primary population centres in Starr County, and all individuals in
each household on selected blocks were enumerated. A random individual aged 20 years and
above with no history of diabetes was selected from each household for a physical
evaluation including an oral glucose tolerance test with a 75 g glucose load. From 1,345 oral
glucose tolerance tests, 350 individuals were classified as having diabetes based on their
fasting or 2 h post-load glucose, and were excluded from consideration as controls.
From the remaining 995 individuals, 990 were selected for genotyping, and after genotype
quality control and pruning related samples, the control sample included 781 unrelated Starr
County residents. Of these, 345 individuals had IGT (defined as a blood glucose level of
7.8–11.0 mmol/l after a 2 h oral glucose tolerance test) or impaired fasting glucose (defined
as fasting blood glucose level of 5.6–6.9 mmol/l after overnight fast) and were included in
the IGT/IFG category as an intermediate phenotype in the ordinal analysis. Table 1
summarises phenotypes measured in the case, IGT/IFG and control groups.
Genotyping and quality control
Genomic DNA was isolated from whole blood of 1,980 unique individuals from Starr
County, and quantified by picogreen. The Affymetrix Genome-Wide SNPArray 6.0 assay
was performed according to manufacturer protocols (Affymetrix, Santa Clara, CA, USA) at
the Center for Inherited Disease Research. Case, IGT/ IFG, and control groups were
randomised to plates. Genotypes were called for 1,890 samples passing quality control (QC)
using both the Affymetrix supported Birdseed v2 [4] calling algorithm as well as the
corrected robust linear model with maximum likelihood classification (CRLMM) [5] and
only calls in complete agreement between the two algorithms were used in analyses.
No samples uniformly failed contrast QC (CQC) and skewness QC (SQC) [6] in the
Affymetrix enzyme-specific subsets as well as the full set of enzyme-specific SNPs. Plate
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effects were examined [6] and three plates were identified as having an excess of SNPs with
low plate-association p values (132, 413, and 1,080 SNPs with p value > 1×10−7 on these
plates). The plate showing the most severe plate effects was comprised of samples that had
failed genotyping previously and had been repeated. Since no systematic bias was apparent
from the battery of quality measures and no single set of individuals consistently clustered
together in a genotype class in the cluster plots of the most plate-biased SNPs (rather poor
clustering and miss-calling were frequently observed in these cluster plots), we chose to
recall the data with CRLMM without removing any individuals. Only autosomal genotypes
with perfect match calls in both the Birdseed and CRLMM datasets (‘consensus calls’) were
carried forward, resulting in a modest reduction in overall call rate (from 0.997 to 0.996
across SNPs and samples). Plate effect analysis was repeated using the consensus calls; the
number of SNPs with plate effect p values <1 × 10−7 for the three plates noted above are 14,
111 and 77, respectively. That a modest plate effect remains in the data may reduce our
power to detect true phenotype associations, but the lack of evidence of differential bias
between cases and controls suggests that the bias will not increase the false positive rate. We
annotated all SNPs with their quality scores from the QC phase, and checked for flags, such
as strong association with a plate, in all top signals.
Using PLINK (http://pngu.mgh.harvard.edu/~purcell/plink/) [7], SNP and individual level
call rates were calculated as well as sex incompatibilities (one mismatch identified and
removed using markers on the X and Y chromosomes). All individuals passed per sample
missingness of <0.1 and 7124 SNPs were removed as a result of missingness >0.1. Identical-
by-descent (IBD) estimations were calculated in PLINK and an ‘unrelated’ cohort of 1,618
samples was created with a proportion of pairwise sharing IBD less than 0.28, weighting
inclusion of cases and higher call rate. Individual and plate level heterozygosity was
estimated in PLINK and no outliers observed. SNPs with minor allele frequency (MAF)
<0.01 were removed. Departures from Hardy–Weinberg equilibrium were calculated and
flagged in the full sample, cases, and controls.
Major ancestry group components for the unrelated admixed sample in a SNP set pruned of
local and long-distance linkage disequilibrium (LD) were calculated in EIGENSTRAT [8]
(Fig. 1a); however, neither of the first two principal components were found to be
significantly correlated with type 2 diabetes (mean regression p values were 0.18, 0.39, with
Pearson correlation coefficients between covariate and phenotype of 0.005 and 0.021,
respectively), similar to our previous findings [9]. Although we did not see significant
correlation of type 2 diabetes and European admixture in the Starr County sample, strong
correlation was observed in the Mexico City study (Fig. 1b). To prevent excessive false
positive rates, all analyses in the Mexico City sample controlled for the distribution along
the primary axis of variation. For additional details of covariates in this sample please refer
to the companion paper [10].
Imputation
We performed imputation in MACH 1.0 [11, 12] from consensus call genotypes with MAF
>0.01 in 1,618 Starr County Mexican-Americans to the full panel of CEU (Centre d’Etude
du Polymorphisme [Utah residents with northern and western European ancestry]), YRI
(Yoruba in Ibadan, Nigeria), and JPT (Japanese in Tokyo, Japan) + CHB (Han Chinese in
Beijing, China) HapMap2 phased polymorphic SNPs from release 22 [13]. In total 137,532
SNPs with an estimate of the squared correlation between imputed and true genotypes,
r2≤0.7 (as estimated by MACH) were removed. An additional 2,616 SNPs with MAF <0.01
were removed, resulting in 1,829,586 genotyped or imputed markers for analyses.
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Type 2 diabetes association analyses
We used SNPtest [14] to calculate the Armitage trend test using covariates and the option
score, which specifies a missing-data likelihood test. Additionally, the missing-data
likelihood test was extended to a three-category (cases, IGT/IFG, and controls) ordered
logistic regression using the same covariates, and implemented in R [15]. We tested the
significance of the correlation of covariates in PLINK. In Starr County, 56% of people aged
70 years and older have diabetes, suggesting that substantial numbers of those with non-
normal or even normal glucose tolerance will ultimately develop diabetes. Therefore, to
generate a more meaningful covariate for age, we used the age at diagnosis (dxage) for cases
and the age at enrolment for the controls. In the case–control analysis as well as in the data
including the IGT/IFG category, age/ dxage, sex and BMI were significantly correlated with
phenotype (mean regression p values across directly interrogated SNPs were <1×10−34,
<1×10−4 and <1× 10−3, with Pearson correlation coefficients between covariate and ordinal
phenotype of 0.36, 0.08 and 0.15 respectively).
Meta-analysis
Type 2 diabetes association results from SNPtest in Mexicans from Mexico City were
combined with results from the associations in the Starr County sample using SNPtest’s
companion program META [16]. We performed principal component analysis (PCA) in
EIGENSTRAT on a local and long-distance LD-pruned SNP set in the Mexico City sample
as well as together with parental populations, to check homogeneity between the samples
(Fig. 1b, c). Population substructure of the samples within the context of HapMap CEU,
YRI, CHB + JPT, and Mexican-American samples from Los Angeles, as well as samples
from Bolivians, Peruvians, and Nahua, Mayan, and Spanish populations [17], was largely
overlapping, suggesting the samples are derived from similar parental populations; the Starr
County sample exhibited more European ancestry. The score method in SNPtest generates a
relative information measure on the scale of (0,1) of the observed statistical information
from the imputation for the estimate of allele frequency of the SNPs, and was used to assess
confidence in the meta-analysis p values. Reported p values have a combined score statistic
≥0.5, MAF>0.05 and p value <0.05 in each study, and a meta-analysis p value <0.001
showing the same direction of effect.
eQTL analysis
The top type 2 diabetes association signals from SNPtest and from the three-category
ordered logistic regression were evaluated for their effect on transcript levels in LCLs,
muscle, and adipose tissue. The set of eQTLs in lymphocytes among the type 2 diabetes
associated SNPs were retrieved from SCAN [18], which holds the results of eQTL mapping
of HapMap SNPs from 90 CEU and 90 YRI samples, to transcriptional expression evaluated
in LCLs from these individuals by the Affymetrix GeneChip Human Exon 1.0 ST Array
(Affymetrix). For the analyses of muscle and adipose eQTLs, samples were chosen from
among 184 study participants for availability of both tissues, and are described in Sharma et
al. [19]. Sixty-two study participants at the tails of the distribution of insulin sensitivity (p
value <1×10−5) adjusted for age, sex, BMI and per cent fat were genotyped on the Illumina
1M platform (Illumina, San Diego, CA, USA) using standard Illumina protocols. Transcript
levels were assayed using Human Whole Genome 4×44 arrays (Agilent Technologies, Santa
Clara, CA, USA). eQTL mapping in each tissue was done by testing each marker for the
additive effect of allele dosage on normalised probe-level expression intensity. In our
annotations, the best proxy SNPs were determined for those type 2 diabetes associated SNPs
not directly typed on the Illumina platform used in the eQTL analyses of muscle and adipose
tissues.
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Using SNP eQTL annotations in LCLs, and adipose and muscle tissues, we conducted
simulations to test for an enrichment of eQTLs (p value <1 × 10−4) among the top signals (p
value <1×10−3) associated with type 2 diabetes. We generated 1,000 random SNP sets, each
of the same size (n=722) as the original list of LD-pruned top signals (r2>0.30), containing
variants matched on MAF distribution, sampled without replacement from the set of typed
SNPs on the Illumina 1M platform; MAF matching was done by drawing from the platform
SNPs, which had been grouped into discrete MAF bins, each spanning 5% of the allele
frequency spectrum. These simulations (n = 1,000) yield an empirical p value, calculated as
the proportion of simulations in which the number of eQTLs exceeds the observed number,
Q, in the list of top type 2 diabetes signals.
Results
Association and meta-analyses
All analyses were performed using the combined age/dxage measurement and sex as
covariates and association tests were conducted with and without correcting for BMI. We
estimated the inflation factors (the ratio of the trimmed means of the observed and expected
values), λage/dxage+sex=1.034 and λage/dxage+sex+BMI=1.026 in the case–control analysis and
1.038 and 1.023 (respectively) in the three-category ordered logistic regression. The
Manhattan and quantile–quantile (QQ) plots summarising results from the ordinal logistic
regression without BMI as a covariate are presented in Fig. 2a, b (others are in ESM Figs 1–
3). Forty-nine high quality SNPs, with an uncorrected p value <1 × 10−5 in at least one
analysis, fell within 14 genomic regions, and are listed, with p values from the analysis, in
Table 2 and depicted in Fig. 2a (p values for these markers in each analysis can be found in
ESM Table 1). These top signals fall within eight genic regions: PER3, PARD3B, EPHA4,
TOMM7, PTPRD, HNT (also known as RREB1), LOC729993 (also known as SHISA9),
IL34, and six intergenic regions. In general, the SNPs within these genic and intergenic
regions represent single blocks of LD (r2 > 0.7). Aside from the SNPs in PARD3B and
EPHA4, which have MAF of about 0.05, these signals are driven by common variation
(MAF > 0.1) (Table 2). We calculated heterogeneity in META (www.stats.ox.ac.uk/~jsliu/
meta.html); we observed no excess of heterogeneity genome-wide and all Starr County top
signals have heterogeneity p values >1 × 10−4 (Table 2) [20]. Results for SNPs in LD with
previously reported associated type 2 diabetes SNPs from the National Human Genome
Research Institute (NHGRI) catalogue [21], Diabetes Genetics Replication and Meta-
analysis Consortium (expanded dataset) (DIAGRAM+) [22], as well as top signals identified
in the previous GWAS in Starr County [9], were examined in detail (ESM Table 2). We also
examined our results for variation within CAPN10, previously reported as a type 2 diabetes
gene in Mexican-Americans, but key SNPs in the associated CAPN10 haplotypes were
neither directly interrogated nor imputed.
The top meta-analysis signals fell within and near the genes CSMD1 and HNF1A; additional
signals implicated LSAMP, FGF12, RP11-354K1.1, KCNQ1, ANK2, NIPAL2,
RP11-74C3.1, CIT, C22orf30 (also known as PRR14L), EPHB2, MCPH1 and DEPDC5.
Follow-up meta-analysis of top signals from the combined Mexican/Mexican-American
studies with the recent DIAGRAM+ dataset identified genome-wide significant signals (p
value <5×10−8) in or near susceptibility genes HNF1A and CDKN2A/CDKN2B, and
suggestive evidence for IGF2BP2, KCNQ1 and the previously unreported C14orf70. For
additional details of the meta-analyses of these samples and follow-up of top signals in
DIAGRAM+, please refer to the companion paper.
In addition to physical proximity, we considered the roles that SNPs in the top signals play
in transcript prediction. Annotation of LD-pruned top signals (p value <1×10−3, r2<0.3)
from the ordinal regression analysis in Starr County, with sex and age/dxage as covariates,
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identified 258 SNPs predicting transcript levels in LCLs, 289 in muscle, and 359 in adipose
tissue. The mean number of frequency matched SNPs that predict transcript levels in LCLs
in 1,000 simulations was 252 (SD 12.17), suggesting no enrichment. However, the
maximum number of muscle and adipose eQTLs observed in 1,000 simulations was 173 and
193, respectively. The distributions of eQTL counts established by simulations, as well as
the actual observed counts in muscle and adipose tissues, are depicted in Fig. 3a, b (see ESM
Fig. 4 for LCLs). Notably, nearly all of the enrichment in muscle and adipose tissue is
driven by trans-acting eQTLs; only three of the eQTLs observed in muscle, and eight in
adipose tissue, were cis-acting. In addition, we replicated the observed enrichment in muscle
and adipose tissues in the top signals (defined as described above) from the analysis in the
Mexico City sample (Fig. 4a, b). A number of SNPs showing association for type 2 diabetes
in our studies predicted gene expression across multiple tissues; 14 SNPs predict expression
in all three tissues tested (ESM Fig. 5).
Discussion
As studies of genetic association in type 2 diabetes are pursued in non-European
populations, it is important to recognise that, in populations with markedly increased disease
rates, there may be room to improve on the case–control study design. In this case, we
favour an approach that uses more information and recognises the staging of the disease,
enabling us to recover a substantial number of individuals. In general, the results of the
ordinal and binary analyses are very similar, but including the intermediate class allows us
to include more of the individuals in the sample, and should, therefore, provide a more
complete picture of the association of genetic variation with the spectrum of phenotypes
related to type 2 diabetes. Among the top signals in the ordinal analysis is a functional
missense polymorphism in the clock gene PER3. Substantial research has implicated
circadian clock function in metabolic diseases, coronary function and obesity [23–25], but
this signal is not replicated in the Mexico City sample (p value ~0.78).
Another top signal from the Starr County sample, as well as in the meta-analysis with
Mexico City, implicates a previously reported type 2 diabetes risk gene PTPRD. PTPRD,
protein tyrosine phosphatase receptor type delta gene [26], was recently identified by
GWAS in Han Chinese populations [26]. Although the SNPs are both intronic, our result is
1.6 Mb downstream and represents an independent signal from within the gene (the SNPs
are in linkage equilibrium in HapMap CHB + JPT as well as CEU samples). The role of
PTPRD in type 2 diabetes is not yet understood; however, when ablated in mice, genes in
this subfamily induce defects in glucose homeostasis and insulin sensitivity [27, 28].
There is little literature suggesting roles for IL34, TOMM7, HNT or PARD3B, nor the
intergenic regions, in diabetes; however, in HapMap Europeans, LD extends from several of
these top regions to include candidate genes for type 2 diabetes. For example, two intergenic
SNPs on chromosome 12 are in high LD with PRMT8 (r2=0.764), a gene known to
influence lipid levels [29]. Yet, LD with a type 2 diabetes-related gene alone is not sufficient
evidence of a SNP’s functional role. To assess functional consequences of associated
variants, we explored our findings in the context of gene regulation.
Previous studies have identified enrichment of eQTLs in trait associated SNPs [30]. A recent
study into the functional role of type 2 diabetes associated SNPs found an excess of eQTLs
among signals from the Wellcome Trust Case Control Consortium and the Diabetes
Genetics Initiative in muscle and adipose [31, 32]. The enrichment in these cases was driven
almost exclusively by trans-acting eQTLs. This enrichment was robust to thresholds of
eQTL p value (1 × 10−6 was also considered and a similar level of enrichment is still
observed) and threshold of significance of type 2 diabetes association (top 1,000 and top
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10,000 signals were analysed and enrichment was seen in both). We find similar enrichment
in both the Starr County and Mexico City datasets. The lack of enrichment of eQTLs in
LCLs, despite significant enrichment of eQTLs from muscle and adipose tissue, is likely to
be attributable to the fact that LCLs as a cell type are not as relevant as muscle and adipose
tissue to type 2 diabetes risk, and only a proportion of eQTLs are shared across tissues [31,
32]. The number of SNPs predicting transcript level in both muscle and adipose tissue is
markedly higher (178) than those overlapping LCLs (33), suggesting concordance of
regulatory action in muscle and adipose tissues in a large proportion of top type 2 diabetes
associated SNPs in our study. Previous studies of eQTLs in LCLs in top type 1 diabetes
associated loci have found significant enrichment [30], suggesting that lymphoblasts are a
relevant tissue for type 1 diabetes; this is reassuring given the role of autoimmunity in the
disease.
Of the 53 previously reported SNPs considered (drawn from the NHGRI catalogue,
DIAGRAM+, and Hayes et al. [9], and interrogated or represented by proxy SNP in the
Starr County analyses) we identified seven markers with p value <0.05 and odds ratios in the
same direction. These markers are in or near IGF2BP2, WFS1, JAZF1, OR13D1-OR13D3P,
KCNQ1, VPS33B, and EPB41L3-LOC645355. An additional 20 SNPs do not reach
marginal significance in our dataset, but do show odds ratios in the same direction.
Seventeen SNPs have previously reported confidence intervals for the odds ratios which
overlap those observed in the Starr County dataset (all data shown in ESM Table 2).
As in all GWASs of type 2 diabetes published to date, we lack power to detect the kinds of
small effect we now know are likely to contribute to disease risk (see ESM Fig. 6).
However, the absence of support for a number of established type 2 diabetes genes is
notable in this dataset. Of particular interest is the lack of association of SNPs within
TCF7L2, the gene with the strongest associations with type 2 diabetes observed in
Europeans. While the allele frequency of the variant most strongly associated in Europeans
is lower in Asian populations, estimates of the odds ratios were quite similar. In contrast, the
frequency of the risk allele is similar in Mexican-Americans and Europeans, but the odds
ratios are lower in both the Mexican-American and Mexico City datasets; in a fixed effects
meta-analysis of SNP rs7903146 in our data and that of Voight et al. [22], the heterogeneity
p value is 0.05. Our confidence intervals for rs7903146 also overlap, but just barely,
according to DIAGRAM estimates.
The winner’s curse, the tendency of a biased overestimate of effect in the first study to
report an association and be successfully published, may explain the somewhat higher
overestimates of effect in the top signals in the Starr County and Mexico City studies [33].
In addition, ascertainment can contribute to these effects. For example, in Starr County,
patients from families with two or more affected members were specifically targeted for the
GWAS, which improves power, but leads to estimates of effect size that are larger than
would be estimated in an unselected case series. In general, however, lack of replication is
likely to be due to the fact that all studies of type 2 diabetes to date are under-powered to
detect small effects, and therefore only detect association signals from some (probably
different) subset of the contributing variants.
To identify, confirm, and characterise additional genetic risk factors for type 2 diabetes it is
likely that we will need to continue studies in non-European populations, to explore new
study designs and methods of analysis in high-risk groups, and to enhance GWAS with
eQTL and other functional studies.
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Fig. 1.
PCA analysis of (a) study population from Starr County, TX, USA, and (b) study population
from Mexico City. Cases are shown in red, IGT/IFG samples are in green, gluconormal
controls are in blue. Both populations analysed together with a number of ancestral
populations are shown in (c)
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Fig. 2.
Manhattan plot of −log10 (p values) at 1.8 million autosomal SNPs (a) and QQ plot of
observed vs expected p values (b) of results of ordinal regression analysis on type 2 diabetes
adjusted for age/dxage and sex
Below et al. Page 13
Diabetologia. Author manuscript; available in PMC 2013 September 04.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 3.
Simulated distribution of eQTL counts for SNPs with allele frequencies matched to signals
with p value <1 × 10−3 from the ordinal regression on type 2 diabetes adjusted for age/dxage
and sex in the Starr County study population. The black dot represents the actual eQTL
count observed in SNPs with p value <1 × 10−3 in this analysis. Results are shown for
transcription prediction in adipose (a) and muscle (b) tissue
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Fig. 4.
Simulated distribution of eQTL counts for SNPs with allele frequencies matched to signals
with p value <1 × 10−3 from the ordinal regression on type 2 diabetes adjusted for age/dxage
and sex in the Mexico City study population. The black dot represents the actual eQTL
count observed in SNPs with p value <1 × 10−3 in this analysis. Results are shown for
transcription prediction in adipose (a) and muscle (b) tissue
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Table 1
Characteristics of the study population
Characteristic Cases IFG/IGT Controls
n 837 345 436
Sex (n, female) 504 259 299
Age (years) (age at diagnosis in cases) 46.7±10.9 40.9±10.5 37.6±9.0
BMI (kg/m2) 31.8±6.4 31.0±5.8 29.5±6.5
HbA1c (%) 10.9±3.7 NA NA
Data are mean ± SD, unless otherwise indicated
NA, not available
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